<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>国广有话说 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-10-31T20:14:46+08:00</updated>
  <subtitle>立足于客观公正，挖掘发现医药企业价值投资机会</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>【东吴医药】“横看成岭侧成峰”——“秒懂”全球创新药系列研究之靶点掘金（第02期：PARP）【东吴医药朱国广团队】</title>
    <updated>2020-10-31T17:07:17+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-31:/s/JuR5bdU4txl4-Xmgz3yuJA</id>
    <link href="https://mp.weixin.qq.com/s/JuR5bdU4txl4-Xmgz3yuJA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>药明康德三季报点评：Q3业绩表现亮眼，CXO标杆企业未来可期 【东吴医药朱国广团队】</title>
    <updated>2020-10-31T17:07:17+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-31:/s/FCWFg02OGz0rztUvfSg9oQ</id>
    <link href="https://mp.weixin.qq.com/s/FCWFg02OGz0rztUvfSg9oQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>迈瑞医疗三季报点评：Q3略超预期，疫情加速公司海外拓展 【东吴医药朱国广团队】</title>
    <updated>2020-10-30T14:58:36+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-30:/s/AYTjwFRS4yPat5njWBgVXw</id>
    <link href="https://mp.weixin.qq.com/s/AYTjwFRS4yPat5njWBgVXw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>安图生物三季报点评：业绩环比持续改善，发光业务驱动公司未来高增【东吴医药朱国广团队】</title>
    <updated>2020-10-30T14:58:36+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-30:/s/D7EAA_7T_wwHF_ELzdsiDQ</id>
    <link href="https://mp.weixin.qq.com/s/D7EAA_7T_wwHF_ELzdsiDQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>华熙生物三季报点评：收入业绩增速提升，品牌元年值得期待【东吴医药&amp;零售社服】</title>
    <updated>2020-10-30T14:58:36+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-30:/s/9xBbvQa4CsYmhA05_OF6MA</id>
    <link href="https://mp.weixin.qq.com/s/9xBbvQa4CsYmhA05_OF6MA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>复星医药三季报点评：业绩符合预期，创新药物成功出海!【东吴医药朱国广团队】</title>
    <updated>2020-10-30T14:58:36+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-30:/s/9A8wWsyloeN0ll5ZSg0BpA</id>
    <link href="https://mp.weixin.qq.com/s/9A8wWsyloeN0ll5ZSg0BpA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>益丰药房三季报点评：公司规模稳健扩张，Q3净利润大幅增长62%【东吴医药朱国广团队】</title>
    <updated>2020-10-30T14:58:36+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-30:/s/E0tOdE5HRmk9NFTUky7lhQ</id>
    <link href="https://mp.weixin.qq.com/s/E0tOdE5HRmk9NFTUky7lhQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>康龙化成三季报点评：Q3高增持续，全年业绩可期【东吴医药朱国广团队】</title>
    <updated>2020-10-30T14:58:36+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-30:/s/7mox871OPNlDi2QrMETMiw</id>
    <link href="https://mp.weixin.qq.com/s/7mox871OPNlDi2QrMETMiw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>药石科技三季报点评：Q3收入端快速扩大，公司发展前景明朗【东吴医药朱国广团队】</title>
    <updated>2020-10-30T14:58:36+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-30:/s/9TAi9C_6WdcYrZ0iHGbv4A</id>
    <link href="https://mp.weixin.qq.com/s/9TAi9C_6WdcYrZ0iHGbv4A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>老百姓三季报点评：业绩持续稳健增长，门店日均坪效提升【东吴医药朱国广团队】</title>
    <updated>2020-10-30T14:58:36+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-30:/s/v5x6uioyzOpJGf6OtKXZ2g</id>
    <link href="https://mp.weixin.qq.com/s/v5x6uioyzOpJGf6OtKXZ2g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>新产业三季报点评：股权激励费用拖累表观增速，X8快速装机及海外需求推动收入高增长【东吴医药朱国广团队】</title>
    <updated>2020-10-29T14:46:56+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-29:/s/Iq93k_syym-32YWewmYonA</id>
    <link href="https://mp.weixin.qq.com/s/Iq93k_syym-32YWewmYonA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>凯利泰三季报点评：Q3恢复增长，疫情不改中长期发展趋势【东吴医药朱国广团队】</title>
    <updated>2020-10-29T14:46:56+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-29:/s/VYHo9YhAuQmZTIWB6hMCVQ</id>
    <link href="https://mp.weixin.qq.com/s/VYHo9YhAuQmZTIWB6hMCVQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>乐普医疗三季报点评：Q3业绩大幅反弹，创新器械步入收获期【东吴医药朱国广团队】</title>
    <updated>2020-10-29T14:46:56+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-29:/s/BqyiHbOzg3JmhYj95Daahw</id>
    <link href="https://mp.weixin.qq.com/s/BqyiHbOzg3JmhYj95Daahw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>迈克生物三季报点评：Q3业绩大幅超预期，自产产品逐步丰富，有望跻身IVD一线企业【东吴医药朱国广团队】</title>
    <updated>2020-10-29T14:46:56+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-29:/s/W9t0bwGD2jhPCux1g3lLtw</id>
    <link href="https://mp.weixin.qq.com/s/W9t0bwGD2jhPCux1g3lLtw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>伟思医疗三季报点评：Q3稳健增长，看好公司中长期发展【东吴医药朱国广团队】</title>
    <updated>2020-10-29T14:46:56+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-29:/s/aryjAji3evbC0rJ7xoXIpA</id>
    <link href="https://mp.weixin.qq.com/s/aryjAji3evbC0rJ7xoXIpA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>九洲药业(603456)：CDMO跨越式成长，业绩持续高增【东吴医药朱国广团队】</title>
    <updated>2020-10-28T13:49:06+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-28:/s/ayg8AIXeD32JR6hiOZaSmQ</id>
    <link href="https://mp.weixin.qq.com/s/ayg8AIXeD32JR6hiOZaSmQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>爱美客三季报点评：Q3业绩超预期，净利率水平再提升【东吴医药&amp;社服零售】</title>
    <updated>2020-10-28T13:49:06+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-28:/s/a0PzKsNf2kMoYRP-BAJKhA</id>
    <link href="https://mp.weixin.qq.com/s/a0PzKsNf2kMoYRP-BAJKhA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>昊海生科三季报点评：业绩逐季恢复，Q3眼科骨科实现双位数增长【东吴医药朱国广团队】</title>
    <updated>2020-10-28T13:49:06+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-28:/s/cYlyi8B11VDbCO2QeWDpig</id>
    <link href="https://mp.weixin.qq.com/s/cYlyi8B11VDbCO2QeWDpig" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>信邦制药三季报点评：经营业绩逐季恢复，战略发展医疗服务【东吴医药朱国广团队】</title>
    <updated>2020-10-28T13:49:06+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-28:/s/nmSFvIiCKZFCSZNEcEawXg</id>
    <link href="https://mp.weixin.qq.com/s/nmSFvIiCKZFCSZNEcEawXg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>昂利康三季报点评：Q3净利超预期，公司加速步入增长期【东吴医药朱国广团队】</title>
    <updated>2020-10-28T13:49:06+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-28:/s/M0pE_y0AvEfi6ESEei1zjw</id>
    <link href="https://mp.weixin.qq.com/s/M0pE_y0AvEfi6ESEei1zjw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>